TIDMWWH

Worldwide Healthcare Trust PLC

22 November 2018

London, UK, 22 November 2018

Edison issues review on Worldwide Healthcare Trust (WWH)

Worldwide Healthcare Trust (WWH) is managed by Sven Borho and Trevor Polischuk of specialist healthcare investor OrbiMed. The managers are positive on the outlook for healthcare stocks in 2019, following a volatile period for global equities so far in 2018. They see reduced political pressure on the sector following the US mid-term elections and believe there will be more of a focus on company fundamentals. The managers cite a series of novel therapeutic products under development, which could meaningfully bolster the revenues and earnings of companies that can successfully bring these drugs to market. In addition, they suggest that an increase in mergers and acquisitions could also focus investor attention on the healthcare sector's potential.

WWH's share price is trading at a 1.9% premium to its cum-income NAV. This compares with an average 0.5% premium over the last 12 months and an average 2.9% discount over the last five years. The board targets a maximum discount of 6%, but has not repurchased any shares since FY17, although share issuance has been high (Exhibit 1). While WWH aims to generate long-term capital growth, it also offers a 0.7% dividend yield.

Click here to view the full report.

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

   LinkedIn        https://www.linkedin.com/company/edison-investment-research 
   Twitter           www.twitter.com/Edison_Inv_Res 
   YouTube       www.youtube.com/edisonitv

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRABTBATMBTTBAP

(END) Dow Jones Newswires

November 22, 2018 10:28 ET (15:28 GMT)

Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Finsbury Worldwide Pharm Charts.
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Finsbury Worldwide Pharm Charts.